{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/accelerating-apac-region-clinical-ophthalmology-trials#webpage",
"url": "https://www.fortrea.com/insights/accelerating-apac-region-clinical-ophthalmology-trials",
"name": "Accelerating APAC region clinical ophthalmology trials",
"description": "This Fortrea case study explores how dry eye disease clinical trials were maintained across APAC research sites during significant operational disruption caused by COVID-19 restrictions in China. The content focuses on dry eye disease clinical trials, APAC trial operations, ophthalmology site collaboration, patient enrollment continuity, and regional clinical trial management strategies used to support ongoing study execution during evolving operational conditions. The case study highlights challenges related to site coordination, enrollment delays, communication barriers, operational adaptability, and maintaining ophthalmology trial continuity across multiple regional research sites during pandemic-related disruption. Fortrea discusses approaches used to strengthen collaboration with ophthalmology investigators and research teams, support patient enrollment continuity, and maintain study timelines despite changing operational limitations. By integrating regional coordination with flexible operational planning and ophthalmology site engagement strategies, the case study provides insights into maintaining dry eye disease clinical trials across APAC during complex operational disruption scenarios"
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Accelerating APAC region clinical ophthalmology trials",
"item": "https://www.fortrea.com/insights/accelerating-apac-region-clinical-ophthalmology-trials"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/accelerating-apac-region-clinical-ophthalmology-trials#casestudy",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/accelerating-apac-region-clinical-ophthalmology-trials#webpage"
},
"headline": "Clinical Ophthalmology Trials for Dry Eye Disease Across APAC Research Sites | Fortrea Case Study",
"description": "This Fortrea case study explores how dry eye disease clinical trials were maintained across APAC research sites during significant operational disruption caused by COVID-19 restrictions in China. The content focuses on dry eye disease clinical trials, APAC trial operations, ophthalmology site collaboration, patient enrollment continuity, and regional clinical trial management strategies used to support ongoing study execution during evolving operational conditions. The case study highlights challenges related to site coordination, enrollment delays, communication barriers, operational adaptability, and maintaining ophthalmology trial continuity across multiple regional research sites during pandemic-related disruption. Fortrea discusses approaches used to strengthen collaboration with ophthalmology investigators and research teams, support patient enrollment continuity, and maintain study timelines despite changing operational limitations. By integrating regional coordination with flexible operational planning and ophthalmology site engagement strategies, the case study provides insights into maintaining dry eye disease clinical trials across APAC during complex operational disruption scenarios",
"genre": "Case Study",
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2024-10-15",
"dateModified": "2024-10-15",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2025-01/CS_0073_OHPTH_APAC_0324_HighRes.pdf",
"encodingFormat": "application/pdf"
}
}
]
}